2014 Archived Content
Bill Abbott, Vice President, Business Development, Acurian
Michael Agard, Principal Consultant, Clinical and Regulatory Optimization, Paragon Solutions
Salvatore Alesci, M.D., Ph.D., Vice President, Scientific Affairs, PhRMA
Munther Baara, Senior Director, Development Business Technology at Pfizer
Charles Barr, M.D., Head, Evidence Science & Innovation, Group Medical Director, US Medical Affairs, Genentech, Inc.
Rhonda Benotti, Business Manager, Strategic Outsourcing, Genentech, Inc.
Nadia Bracken, Clinical Program Manager, Clinical Operations, Biotie Therapies
Bonnie Brescia, Founding Principal, BBK Worldwide
Kyle Brown, CEO, PatientCrossroads
Jeri Burtchell, Patient Advocate Blogger, Gilenya and Me
Zhaohui (John) Cai, M.D., Ph.D., Director, Biomedical Informatics, Clinical Medicines Development, AstraZeneca Pharmaceuticals, Inc.
Hui Cao, M.D., Ph.D., Senior Director, Personalized Healthcare, R&D Information, AstraZeneca
Katherine Cartwright Norris, Director, Compliance & Integrity Programs, Becker & Associates Consulting; former Director, Corporate Compliance, The Spectranetics Corporation
Chris Chan, Director, R&D Financial Planning and Analysis, Onyx Pharmaceuticals
Adam Chasse, COO, RxTrials
Shailesh Chavan, M.D., Senior Director, Clinical Research, Medical Affairs & Drug Safety, Biotest Pharmaceuticals Corporation
Janet Christoff, Clinical Trial Manager, Sanofi Pasteur
Mark A. Collins, Ph.D., Director, Marketing, BioFortis, Inc.
Larissa Comis-Tis, Director, Clinical Strategy, Thomson Reuters
Brenda Conger, Founder and Executive Director, CFC International
Patricia Cornet, Associate Director, Advocacy, Global Recruitment & Analytics, Bristol-Myers Squibb
Andre Daniels, Ph.D., Executive Medical Director, Global Safety, Amgen
Nick Darwall-Smith, Vice President, CRS Technology, PAREXEL
Nancie Deckard, Biomarker CRA, Clinical Operations, Duke Clinical Research Institute (DCRI)
Carla DeMuro, Head, Patient Reported Outcomes, RTI Health Solutions
Elizabeth Desrosiers, Director, Global Trial Management, Merck & Co., Inc.
Reinerio Deza, M.D., Head Global Pharmacovigilance, CDMA Management, Cubist Pharmaceuticals, Inc.
Kuno Didier van der Post, MSc, Ph.D., Senior Vice President, Business Development, OmniComm Systems, Inc.
Jessica Dolfi, Senior Business Consultant, Medidata Solutions
Christopher Dowd, Clinical Research Program Manager, Medical, The Cystic Fibrosis Foundation
Robert Dracker, M.D., Medical Director, Summerwood Pediatrics; Member, Pediatric Advisory Committee, FDA
Halleluya Dunn, Clinical Recruitment Manager, Patient & Physician Services, United BioSource Corporation
Barbara Elashoff, CEO, Patient Profiles, LLC
Silke Ewald, M.D., Head, Trial Feasibility Assessment, Bayer HealthCare AG
Jane Fang, Ph.D., R&D IS Lead, Clinical Business Management & Analytics, MedImmune
Erin Fassett, Clinical Transplant Research Nurse, Baylor Research Institute
Nikki Fink, Director, Patient Access and Retention Services, PRA International
Mary Flack, M.D., Vice President, Clinical Research, Nanobio
Bruno Gagnon, Vice President, Clinical Operations, BioMarin Pharmaceutical, Inc.
Heidi Gambino, Chief Administrative Director, Surgery, Boston University Medical Center
Rose Gerber, Director, Communications and Patient Advocacy, Community Oncology Alliance
Jayne Gershkowitz, Vice President, Patient Advocacy & Public Policy, Amicus Therapeutics, Inc.
Kenneth Getz, Director, Sponsored Programs, Tufts CSDD; Chairman, CISCRP
Melynda Geurts, Vice President Operations, DAC Patient Recruitment Services
Alicia Gilsenan, Ph.D., Senior Director, Epidemiology, RTI Health Solutions
Abraham Gitterman, Associate, Arnold & Porter, LLP
Lucas M Glass, Managing Director, Routine Recovery, LLC
Gretchen Goller, Senior Director, Therapeutic Expertise, Patient Access and Retention Services, PRA International
Kathleen Greenough, Senior Manager, Clinical Systems & Technology, Biogen Idec
Bill Gwinn, MBA, Vice President, Clinical Informatics Solutions, Optum
Kathleen Hanlon, Senior Project Manager, Infinity Pharmaceuticals
Beth Harper, President, Clinical Performance Partners, Inc.
Jamie Heywood, Co-Founder and Chairman, PatientsLikeMe
Bill Hirokawa, Pharm.D., Coordinator, Investigational Drug Section, Pharmaceutical Services, Ronald Reagan UCLA Medical Center
Toby Ann Holetz, Global Head, Global Aggregate Spend Reporting Team, Quintiles
Kelly Hollis, MBA, Global Head, Surveys and Observational Studies, RTI Health Solutions
Kirstin Holzapfel, Deputy Director, Global Clinical Data Center, Bayer / Global Clinical Operations
Jackie Hoover, Vice President, Account Management, C3i, Inc.
Ty Hoover, M.D., J.D., FCLM, FCAP, Director, Biorepository Regulatory Support, University of Texas MD Anderson Cancer Center
Denise Hopkins, Pharm.D., Senior Director, Late Phase Research, Optum
Keith Howells, Senior Vice President, Development, OmniComm Systems, Inc
Michael Howley, Ph.D., Clinical Associate Professor, Business, LeBow College of Business, Drexel University
Chris Hoyle, Executive Director, Elite Research Network
Adwoa Hughes-Morley, NIHR Doctoral Research Fellow, MRC North West Hub for Trials Methodology Research, Centre for Primary Care, Institute of Population, The University of Manchester
Barbara Isquith Arone, MS, Senior Director, Service Operation, Real-World Late Phase, Quintiles
Michael Jasper, Ph.D., Director, Clinical Documentation, Genzyme, a Sanofi Company
Les Jebson, Executive Director, Diabetes Center of Excellence, University of Florida Academic Health Center
Otis Johnson, Executive Director, Clinical Informatics & Feasibility, inVentiv Health, Inc.
Janet Jones, Vice President, Access to Patients, Synexus Ltd.
Michael Jones, Senior Director, Global Site Development, Clinical Operations, Eli Lillly & Co.
Elke Jordan, Ph.D., Manager, Clinical Development, Bavarian-Nordic GmbH
Aaron Kamauu, M.D., President & CEO, Anolinx, LLC
Suresh Kannan, Vice President Products, Clinical Trial Optimization Solutions, IMS Health
Jeffrey Kasher, Ph.D., Vice President, Global Clinical Trial: Materials, Implementation and Transformation, Eli Lilly & Co.; TransCelerate Operations Committee Member
Vanessa Kemp, Manager, Project Controls; Master Capital Planning, Engineering, Novartis
Francis Kendall, Global Head, Statistical Programming and Analysis, GLIDE Future Investigation Team Lead, Genentech
Jackie Kent, Director, Clinical Development Information & Optimization (CDIO), Eli Lilly & Co.
Joe Kim, MBA, Director, Clinical Operations, Shire Pharmaceuticals
Lee King, Vice President, Operations and Strategic Programs, ICON Commercialisation and Outcomes
Andrea Kirby, Director, Enterprise Integration and Customer Collaboration, Merck & Co, Inc.
Cathy Koepper, Director, Global Registry Operations, Genzyme, a Sanofi Company
Debi Koltenuk, Vice President, Products and Services, sampleminded
Paul Konstant, Manager, Translational Informatics, Janssen Pharmaceutical Co.
Greg Koski, Ph.D., M.D., Co-Founder & President, ACRES; former Director, Office for Human Research Protections, U.S. Department of Health and Human Services
Anna Kravets, Director, User Experience Strategy & Realization, Merck & Co., Inc.
Subha Krishnan, CCDM Principal Data Manager, Optum
Lisa La Luna, Senior Vice President, Corporate Development & Implementation, ePharmaSolutions
Andrew Lee, Senior Vice President & Head, Global Clinical Operations, Genzyme Corp., a Sanofi Co.
Wei Li, Functional Manager, Strategic Outsourcing, Genentech, Inc.
Craig Lipset, Head, Clinical Innovation, Worldwide Research & Development, Pfizer
Victor Lobanov, Ph.D., Executive Director, Data Sciences, Informatics, Covance
Robert Loll, Vice President, Business Development & Strategic Planning, Praxis
Charles Love, Vice President, Clinical Affairs, Endologix, Inc.
Sarah Luijpers, Director, Global Recruitment Operations, Forest Research Institute, Inc.
Jamie MacDonald, CEO, INC
Marina Malikova, Ph.D., Executive Director, Surgical Translational Research: Operations and Compliance, Surgery, Boston University Medical Center
Kathleen Mandziuk, MPH, RN, Senior Scientific Affairs Director, PRA Late Phase Services
Deborah Manzo, Senior Director, Clinical Business Operations & Transformation, Clinical Operations, AbbVie
Sylvia Marecki, Ph.D., Senior Director, Product Management & Strategy, Product Management, Citeline
Elizabeth Mascherino, Associate Director, Clinical Operations, Shire Pharmaceuticals
Jomol Mathew, Ph.D, Director, Clinical and Translational Informatics, IS, Dana-Farber Cancer Institute
Richard Mayewski, Associate Director, Clinical Trial Intelligence, Novartis
Juliet McBride, Associate, King & Spalding
Ruth McHenry, Managing Director, Infinata, Inc.
Kelly McKee, Associate Director, Clinical Research, Global Trial Optimization, Merck & Co., Inc.
Kevin McNulty, Director, Product Marketing, Life Sciences, Intralinks, Inc.
Christopher McSpiritt, Principal Consultant, Clinical and Regulatory Optimization, Paragon Solutions
Brenda Medina, former Director, Global Head, Clinical Business Operations, Eisai, Inc.
Kenneth Mark Mills, Director, Clinical Scientific Data Warehouse, Pfizer
Liz Moench, President & CEO, MediciGlobal, Inc
Kim Mooney, Associate Director, Patient Advocacy, Ultragenyx Pharmaceutical Inc.
Helen Moore, Ph.D., Program Director, Biorepositories & Biospecimen Research Branch Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute
Eric Morfin, Senior Director, Project Management, Allergan
Nancy Mulligan, Senior Director, Operations, Patient & Physician Services, UBC
Meredith Nahm, Ph.D., Associate Director, Clinical Research Informatics, Biomedical Informatics Core, Duke Translational Medicine Institute
Ramzi Najm, Vice President, R&D Information and Technology Management, Allergan
Nariman Nasser, Senior Director, Participant Recruitment & Study Management Services, Clinical & Translational Science Institute, University of California, San Francisco
Nick Neri, Vice President, Product Development, eClinical Insights
Derenda Nichols, Vice President, Operations Americas, Mapi
Daniel O’ Connor, InnovoCommerce
Al O. Pacino II, President, HealthCarePoint.com
Krista Payne, Executive Director, Value Demonstration within Peri- and Post-Approval Services; Senior Research Scientist, United BioSource Corporation
Nye Pelton, Clinical Operations Portfolio Manager, Clinical Research, Eli Lilly & Co.
Gerson Peltz, M.D., Medical Director, Global Pharmacovigilance and Epidemiology, Bristol-Myers Squibb
Jane Perlmutter, Ph.D., MBA, President and Founder, Gemini Group; Steering Committee Member, Clinical Trials Transformation Initiative (CTTI)
Christine Pierre, President, The Society for Clinical Research Sites (SCRS)
Joe Popowicz, Principal Consultant, Emergent Clinical Consulting; former Director, Clinical Operations, Stryker Orthobiologics
Gary Puckrein, Ph.D., President and Chief Executive Officer, National Minority Quality Forum
Teresa Raich, Ph.D., Vice President, Nanosphere
Andrea Renninger, Head, BioBank Operations; Senior Manager, Clinical Coordination, Eisai, Inc.
Irina Ringler, Director, Feasibility & Clinical Informatics, inVentiv Clinical Trial Recruitment Solutions
Terry Robins, Consultant; former, Global Director, Scientific Affairs, Quest Diagnostics
Jorge Rodriguez-Larrain, M.D., Head, Global Site Management, Global Clinical Operations, Alcon
Stewart Rosen, M.D., Vice President, Medical Affairs, Health Management Solutions, Quintiles
Jessica Saucier, Clinical Transplant Research Nurse, Baylor Research Institute
Peggy Schrammel, Vice President & Global Head, Portfolio Management, PACE PAREXEL
Colin Scott, M.D., Senior Director, Respiratory Development, Clinical Development, Forest Research Institute, Inc.
Gary Secrest, CTO and Vice Chairman, SAFE-BioPharma Association
Edward Seguine, CEO, Clinical Ink
Lisa Sergas, Manager, Clinical Outsourcing, Medivation
Nigam Shah, Ph.D., Assistant Professor, Medicine & Biomedical, Informatics, Stanford Center for Biomedical Informatics Research
Heidi Shea, Director, Vendor & Outsourcing Management, Vertex
Katheryn Shea, Vice President, BioServices Operations, Precision Bioservices, Inc.
Mollie Shields-Uehling, President and CEO, SAFE-BioPharma Association
Eric Silberstein, Co-founder & CEO, TrialNetworks
Andrew Smith, Global Transparency Reporting Associate Consultant, Eli Lilly and Co.
Ellie Smith, Global Clinical Site Developer, Alcon
Tina Soares, Senior Director, Trial Coordination Site Management, GCO, Johnson & Johnson
Simon Sparkes, Senior Vice President, Clinical, ArisGlobal
Manfred Stapff, M.D., Executive Director, Global Medical Operations, Forest Laboratories
Daniel Steenblik, Vice President, Technology and Operations, sampleminded
Matthew Stumm, Principal, Creative & Media Strategy, BBK Worldwide
Thomas Sullivan, President, Rockpointe Corporation
Ramita Tandon, Senior Vice President & General Manager, Patient Outcomes, inVentiv Health, Inc.
Sameer Tandon, Global Supplier Performance & Innovation (SP&I) Manager, R&D, Outsourcing, Novartis
Judith Teall, Director, Clinical Excellence, Operations, Exco InTouch
Piet Theisohn, Director, Resource Management & Business Support, Global Clinical Development, Bayer Healthcare Pharmaceuticals
Stuart Thiede, Senior Vice-President & General Manager, Global Payment Services, CFS Clinical (CFS)
Kate Trainor, Vice President & Global Head, Project Management &Technology, PACE PAREXEL
Lisa Vaughan, Head, US Clinical Site Management, Alcon
Rita Viegas, Clinical Operations Lead, Biogen Idec
Christina Villar, MPH, Director, Clinical Affairs, Johnson & Johnson Vision Care, Inc.
Lee Walke, Senior Director, Biometrics, Mapi Real World Evidence
John Walker, Director, NIBR IT, Novartis Institutes for BioMedical Research, Inc.
Amelia Wall Warner, President, Board of Directors, Gentris Corporation; former, Head Clinical Pharmacogenomics and Clinical Specimen Management, Merck
Neal Weinreb, M.D., Director, Gaucher Disease - Fabry Disease Treatment Center; University Research Foundation for Lysosomal Storage Diseases
Chunhua Weng, Ph.D., Florence Irving Assistant Professor of Biomedical Informatics, Columbia University
Dan White, Vice President, Global Clinical Operations, Quintiles
Seth Whitelaw, S.J.D., Director, Health Sciences Compliance, Deloitte & Touche LLP
Adam Wilcox, Ph.D., Director, Medical Informatics, Intermountain Healthcare
Kenneth A. Wilke, Consultant; former Director, Clinical Pharmacogenomics and Clinical Specimen Management, Merck
Kevin Williams, Vice President, Corporate Development & Marketing, CFS Clinical (CFS)
Patty Wood, President, NBIA Disorders Association
Barbara Wuebbels, Vice President, Patient Advocacy and Medical Affairs, Audentes Therapeutics
Fei Xue, M.D., Observational Research Director, Center for Observational Research (CfOR), Amgen, Inc.
Brenda Yanak, Ph.D., Director, Precision Medicine Leader, Clinical Innovation, Pfizer
Sean Zhao, M.D., Ph.D., former Pharmaceutical Executive in Global Safety Organization
Anita Zubak, Director, Business Systems Integration, Merck & Co, Inc.